Sernova-Logo-color-High-Quality-Web.jpg
Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA
November 27, 2023 07:19 ET | Sernova Corp.
LONDON, Ontario and WINDHAM COUNTY, Conn., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today...
Sernova-Logo-color-High-Quality-Web.jpg
Sernova Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System™ at the 2023 IPITA-IXA-CTRMS Joint Congress
October 30, 2023 07:00 ET | Sernova Corp.
LONDON, Ontario and WINDHAM COUNTY, Conn., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today...
Sernova-Logo-color-High-Quality-Web.jpg
Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System™ for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress
October 27, 2023 07:00 ET | Sernova Corp.
All six patients in the first cohort (Cohort A) were successfully implanted with the 8-channel Cell Pouch System with post-transplant follow-up periods ranging from 6 months to 3.5 years;5 of 6...
Sernova-Logo-color-High-Quality-Web.jpg
Sernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA Congress
October 11, 2023 07:00 ET | Sernova Corp.
Dr. Piotr Witkowski presenting new data from ongoing Phase 1/2 clinical trial of the Cell Pouch System™ in patients with type 1 diabetes (T1D) Dr. Alice Tomei presenting preclinical data on...
Sernova-Logo-color-High-Quality-Web.jpg
Sernova Presents Compelling New Data on the Cell Pouch System™ as a Promising Treatment for Post-Operative Hypothyroidism at the 2023 American Thyroid Association Annual Meeting
September 29, 2023 09:50 ET | Sernova Corp.
LONDON, Ontario and WINDHAM COUNTY, Conn., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today...
Sernova-Logo-color-High-Quality-Web.jpg
Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22
September 14, 2023 16:05 ET | Sernova Corp.
LONDON, Ontario and WINDHAM COUNTY, Conn., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today...
Sernova-Logo-color-High-Quality-Web.jpg
Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update
September 13, 2023 07:00 ET | Sernova Corp.
- Introduction of New CEO Cynthia Pussinen and Recently Appointed Chief Business Officer, Dr. Modestus Obochi, on September 15, 2023 - - Business Update, Strategy & Outlook Call on October 5,...
Sernova-Logo-color-High-Quality-Web.jpg
Sernova Provides Development Update on Proprietary Cellular Conformal Coating Technology in Combination with Cell Pouch Device
September 07, 2023 07:00 ET | Sernova Corp.
LONDON, Ontario and WINDHAM COUNTY, Conn., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today...
Sernova-Logo-color-High-Quality-Web.jpg
Sernova Corporation Announces the Appointment of Cynthia Pussinen as CEO
September 05, 2023 07:00 ET | Sernova Corp.
Industry veteran with deep commercial experience joins to lead the next stage of growth and development Dr. Philip Toleikis will serve as Chief Technology Officer  Sernova to host investor calls ...
Sernova-Logo-color-High-Quality-Web.jpg
Sernova Expands Leadership Team with Appointment of Modestus Obochi, Ph.D., MBA, as Chief Business Officer
July 26, 2023 07:00 ET | Sernova Corp.
LONDON, Ontario, July 26, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a clinical-stage company and leader in cell therapeutics, today announced the appointment...